Lexapro and Daliresp drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Lexapro (escitalopram oxalate) and Daliresp (roflumilast). Common drug interactions include vaginal discharge among females and insomnia among males.
The phase IV clinical study analyzes what interactions people have when they take Lexapro and Daliresp. It is created by eHealthMe based on reports of 100 people who take the same drugs from the FDA, and is updated regularly.
What is Lexapro?
Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.
What is Daliresp?
Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.
100 people who take Lexapro and Daliresp together, and have interactions are studied.

What are the common drug interactions of Lexapro and Daliresp, by gender? *:
female:
- Vaginal discharge
- Erythema (redness of the skin)
- Haemorrhage (bleeding)
- Head discomfort
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Pain in extremity
- Productive cough
- Swelling
- Decreased appetite
- Hypoaesthesia (reduced sense of touch or sensation)
male:
- Insomnia (sleeplessness)
- Cardiac failure congestive
- Epistaxis (bleed from the nose)
- Gait disturbance
- Panic attack
- Weight decreased
- Abdominal pain
- Chest pain
- Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
- Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
What are the common drug interactions of Lexapro and Daliresp, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Pneumonia
- Pruritus (severe itching of the skin)
- Pyrexia (fever)
- Rash
- Rhinorrhoea (watery mucus discharge from the nose)
- Sinus congestion (blockage of sinus)
- Skin mass
- Urticaria (rash of round, red welts on the skin that itch intensely)
- Immune system disorder
- Pulmonary mass
60+:
- Confusional state
- Dyspnoea (difficult or laboured respiration)
- Headache (pain in head)
- Nausea (feeling of having an urge to vomit)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Dizziness
- Lymph node abscess (pus in lymph node)
- Weight decreased
- Chronic kidney disease
- Renal failure (kidney dysfunction)
What are the existing conditions these people have? *
- Immunodeficiency Common Variable: 20 people, 20.00%
- Asthma: 10 people, 10.00%
- Multiple Myeloma (cancer of the plasma cells): 8 people, 8.00%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 7.00%
- High Blood Cholesterol: 7 people, 7.00%
- Dyspnea (difficult or laboured breathing): 7 people, 7.00%
- Fluid Retention (an abnormal accumulation of fluid in the blood): 6 people, 6.00%
- Stress And Anxiety: 5 people, 5.00%
- Pain: 5 people, 5.00%
- High Blood Pressure: 5 people, 5.00%
* Approximation only. Some reports may have incomplete information.
Do you take Lexapro and Daliresp?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Lexapro and Daliresp:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Lexapro:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Daliresp:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Lexapro and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Daliresp and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
- O’Brien FE, O’Connor RM, Clarke G, Donovan MD, Dinan TG, Griffin BT, Cryan JF, "The P-glycoprotein inhibitor cyclosporin A differentially influences behavioural and neurochemical responses to the antidepressant escitalopram", Behavioural brain research, 2014 Mar .
How the study uses the data?
The study uses data from the FDA. It is based on escitalopram oxalate and roflumilast (the active ingredients of Lexapro and Daliresp, respectively), and Lexapro and Daliresp (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Pravastatin Sodium cause Ill-Defined Disorder? - 6 seconds ago
- Could Gatifloxacin cause Meralgia Paraesthetica? - 6 seconds ago
- Could Xifaxan cause Vomiting Aggravated? - 17 seconds ago
- Drug interactions of Wellbutrin and Pioglitazone - 19 seconds ago
- Could Arnuity Ellipta cause Hyposmia? - 19 seconds ago
- Drug interactions of Loraz and Vitamin E - 26 seconds ago
- Drug interactions of Loraz and Ivabradine Hydrochloride - 27 seconds ago
- Drug interactions of Doxorubicin Hydrochloride and Pantoprazole Sodium - 31 seconds ago
- Drug interactions of Loratadine and Bendamustine Hydrochloride - 36 seconds ago
- Drug interactions of Loraz and Torecan - 36 seconds ago